, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis, World Health Organ Tech Rep Ser, vol.843, pp.1-129, 1994.
Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, pp.513-534, 2009. ,
, , 2016.
Epidemiology of osteoporosis, Trends Endocrinol Metab, vol.3, pp.224-233, 1992. ,
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis, J Bone Miner Res, vol.15, pp.721-760, 2000. ,
Risk of new vertebral fracture in the year following a fracture, JAMA, vol.285, pp.320-323, 2001. ,
Clinical subsequent fractures cluster in time after first fractures, Ann Rheum Dis, vol.68, pp.99-102, 2009. ,
Devising global strategies for fracture-risk evaluation, Joint Bone Spine, vol.74, pp.240-244, 2007. ,
, La densitométrie osseuse. Revue du Podologue, vol.65, pp.25-33, 2015.
Assessment of fracture risk, Osteoporos Int, vol.16, pp.581-590, 2005. ,
Vertebral fracture assessment by new dual-energy X-ray absorptiometry, Bone, vol.50, pp.836-877, 2012. ,
Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment, Curr Osteoporos Rep, vol.7, pp.103-109, 2009. ,
Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA), Radiol Med, vol.117, pp.1374-85, 2012. ,
Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice, Osteoporos Int, vol.17, pp.281-290, 2006. ,
Validity in diagnosing osteoporosis. Observer variation in interpreting spinal radiographs, Eur J Radiol, vol.4, pp.1-3, 1984. ,
Vertebral fracture assessment using a semiquantitative technique, J Bone Miner Res, vol.8, pp.1137-1185, 1993. ,
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures, Osteoporos Int, vol.5, pp.354-70, 1995. ,
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), Curr Med Res Opin, vol.29, pp.305-318, 2013. ,
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years, Osteoporos Int, vol.26, pp.2763-71, 2015. ,
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study, Osteoporos Int, vol.26, pp.2773-83, 2015. ,
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT), J Bone Miner Res, vol.27, pp.243-54, 2012. ,
Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review, Ann Intern Med, vol.161, pp.711-734, 2014. ,
Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, pp.1427-1457, 2001. ,
Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US, Arthritis Rheum, vol.59, pp.474-80, 2008. ,
Mortality in rheumatoid arthritis: 2008 update, Clin Exp Rheumatol, vol.26, issue.5, pp.35-61, 2008. ,
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Ann Rheum Dis, vol.69, pp.964-75, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01778213
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Ann Rheum Dis, vol.75, pp.16-22, 2016. ,
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force, Ann Rheum Dis, vol.75, pp.3-15, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01890959
Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis, Ann Rheum Dis, vol.66, pp.263-269, 2007. ,
Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study, Ann Rheum Dis, vol.63, pp.952-957, 2004. ,
The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years, Arthritis Rheum, vol.52, pp.412-432, 2005. ,
Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature, Clin Exp Rheumatol, vol.26, pp.673-682, 2008. ,
Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.2061-2069, 2006. ,
Risque cardiovasculaire de la polyarthrite rhumatoïde, Revue du rhumatisme, vol.4, pp.281-286, 2014. ,
Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde, Revue du Rhumatisme, vol.81, pp.303-315, 2014. ,
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann Rheum Dis, vol.69, pp.325-356, 2010. ,
Length of life and cause of death in rheumatoid arthritis, N Engl J Med, vol.249, pp.553-559, 1953. ,
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis, Ann Rheum Dis, vol.66, pp.308-320, 2007. ,
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses, Arthritis Res Ther, vol.13, p.139, 2011. ,
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events, Ann Rheum Dis, vol.68, pp.1136-1181, 2009. ,
Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials, Arthritis Rheum, vol.63, pp.1479-85, 2011. ,
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, Ann Rheum Dis, vol.68, pp.25-32, 2009. ,
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials, Rheumatology (Oxford), vol.50, pp.552-62, 2011. ,
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, N Engl J Med, vol.345, pp.1098-104, 2001. ,
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis, Arthritis Res Ther, vol.10, p.45, 2008. ,
Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma, Arthritis Rheum, vol.48, pp.1543-50, 2003. ,
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, vol.73, pp.62-70, 2014. ,
Fractures after rheumatoid arthritis. A population-based study, Arthritis Rheum, vol.27, pp.1353-61, 1984. ,
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis, Arthritis Res Ther, vol.12, issue.4, p.154, 2010. ,
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.3104-3116, 2006. ,
Serum osteocalcin levels in premenopausal rheumatoid arthritis patients, Ann N Y Acad Sci, vol.966, pp.502-509, 2002. ,
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, Arthritis Rheum, vol.43, pp.250-258, 2000. ,
Expression of osteoclast differentiation factor in rheumatoid arthritis, Arthritis Rheum, vol.43, pp.2523-2553, 2000. ,
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis, Ann Rheum Dis, vol.70, pp.2022-2030, 2011. ,
Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis, J Rheumatol, vol.25, pp.1282-1291, 1998. ,
Osteoimmunology: Wnt antagonists: for better or worse?, Nat Rev Rheumatol, vol.5, pp.420-421, 2009. ,
Dickkopf-1 is a master regulator of joint remodeling, Nat Med, vol.13, pp.156-63, 2007. ,
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis, Arthritis Rheum, vol.60, pp.3257-62, 2009. ,
Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept, J Rheumatol, vol.35, pp.2313-2318, 2008. ,
The foot: still the most important reason for walking incapacity in rheumatoid arthritis: Distribution of symptomatic joints in 1,000 RA patients, Acta Orthopaedica, vol.79, pp.257-61, 2008. ,
International Society for Clinical Densitometry. Official positions of the International Society for Clinical Densitometry, J Clin Densitom, vol.7, pp.1-6, 2004. ,
Bone mineral density changes in patients with recent-onset rheumatoid arthritis, Clin Med Insights Arthritis Musculoskelet Disord, vol.4, pp.87-94, 2011. ,
Secondary osteoporosis in patients with an osteoporotic fracture, Best Pract Res Clin Rheumatol, vol.23, pp.769-79, 2009. ,
Glucocorticoid-induced osteoporosis, RMD Open, vol.1, p.14, 2015. ,
2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, pp.493-501, 2014. ,
Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011, J Bone Miner Res, vol.29, pp.1929-1966, 2014. ,
Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries, Arch Osteoporos, vol.11, p.31, 2016. ,
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®), J Rheumatol, vol.37, pp.2221-2226, 2010. ,
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort, Rheumatology (Oxford), vol.51, pp.1662-1671, 2012. ,
Management of glucocorticoidinduced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice, Arthritis Rheum, vol.46, pp.3136-3178, 2002. ,
Long-term persistence and switching patterns among women using osteoporosis therapies: 24-and 36-month results from POSSIBLE US TM, Osteoporos Int, vol.25, pp.2279-90, 2014. ,
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA, Arch Osteoporos, vol.10, p.231, 2015. ,
Gender-and age-related treatment compliance in patients with osteoporosis in Germany, Patient Prefer Adherence, vol.10, pp.2379-85, 2016. ,
The importance of taking care of osteoporosis, Presse Med, vol.40, pp.900-909, 2011. ,
Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views, PLoS ONE, p.11, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01520976
Prevalence of rheumatoid arthritis in France, Ann Rheum Dis, vol.64, pp.1427-1457, 2001. ,
Mortality in rheumatoid arthritis: 2008 update, Clin Exp Rheumatol, vol.26, issue.5, pp.35-61, 2008. ,
Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis, J Rheumatol, vol.25, pp.1282-1291, 1998. ,
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol.54, pp.3104-3116, 2006. ,
Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, pp.513-534, 2009. ,
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force, Ann Rheum Dis, vol.75, pp.3-15, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01890959
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update, Ann Rheum Dis, vol.75, pp.16-22, 2016. ,
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Ann Rheum Dis, vol.73, pp.62-70, 2014. ,
Evidencebased Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian DermatologyRheumatology Comorbidity Initiative, J Rheumatol, vol.42, pp.1767-80, 2015. ,
Impact of a nurse-led programme on comorbidity management and impact of a patient selfassessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA), Ann Rheum Dis, vol.74, pp.1725-1758, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01225510
Care gap in patients with early inflammatory arthritis with a high fracture risk identified using FRAX(®), J Rheumatol, vol.37, pp.2221-2226, 2010. ,
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort, Rheumatology (Oxford), vol.51, pp.1662-1671, 2012. ,
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice, Arthritis Rheum, vol.46, pp.3136-3178, 2002. ,
FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study, PLoS One, vol.8, issue.12, 2013. ,
Vertebral fracture assessment using a semiquantitative technique, J Bone Miner Res, vol.8, pp.1137-1185, 1993. ,
DOI : 10.1002/jbmr.5650080915
Incidental vertebral compression fractures in imaging studies: Lessons not learned by radiologists, World J Radiol, vol.2, pp.399-404, 2010. ,
DOI : 10.4329/wjr.v2.i10.399
URL : https://doi.org/10.4329/wjr.v2.i10.399
Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis, BMC Musculoskelet Disord, vol.13, p.125, 2012. ,
Exploration of risk factors on the occurrence of osteoporotic vertebral fracture in patients with rheumatoid arthritis, Zhonghua Nei Ke Za Zhi, vol.53, pp.852-859, 2014. ,
Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment, Rheumatology (Oxford), vol.49, pp.1303-1313, 2010. ,
Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy, BMC Musculoskeletal Disorders, vol.16, p.300, 2015. ,
The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis, Rheumatology (Oxford), vol.53, pp.821-828, 2014. ,
Radiographic methods for evaluating osteoporotic vertebral fractures, Joint Bone Spine, vol.76, pp.241-248, 2009. ,
DOI : 10.1016/j.jbspin.2008.07.017
Low bone mineral density and fracture burden in postmenopausal women, CMAJ, vol.177, pp.575-80, 2007. ,
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD, J Bone Miner Res, vol.24, pp.1515-1537, 2009. ,
DOI : 10.1359/jbmr.090319
URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.090319/pdf
Secondary osteoporosis in patients with an osteoporotic fracture, Best Pract Res Clin Rheumatol, vol.23, pp.769-79, 2009. ,
DOI : 10.1016/j.berh.2009.09.006
Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture, Osteoporos Int, vol.26, pp.961-969, 2015. ,
Intra and interobserver reliability and agreement of semiquantitative vertebral fracture assessment on chest computed tomography, PLoS ONE, vol.8, p.71204, 2013. ,